News

A recent case report describes a newborn with severe thrombocytopenia who was found to have a novel mutation in the MECOM gene.

Very premature infants exposed to preeclampsia needed more platelet transfusions even though FNAIT was not observed in the sample.

In a recent study, researchers identified the clinical signs that may point to a rare subtype of intracranial hemorrhage.

A group of obstetricians, pediatricians and other healthcare professionals reached a consensus on several aspects of FNAIT care.

Rallybio announced its clinical trial investigating the drug RLYB212, intended for the prevention of FNAIT, was discontinued.

Researchers studied a rare case of prolonged fetal and neonatal alloimmune thrombocytopenia (FNAIT) caused by three different antibody types.

The increase in immunoglobulin administration for a wide range of conditions, including FNAIT, underscores the need to refine care guidelines.

Platelet transfusions are often required to treat FNAIT, however recent evidence suggests that they could produce serious complications.

A newborn with thrombocytopenia, of which FNAIT is a differential diagnosis, was eventually diagnosed with Wiskott-Aldrich syndrome.

A recent case report highlighted how a well-planned approach can help prevent FNAIT in pregnancies at higher risk.